Entering text into the input field will update the search result below

SNZZF Senzime AB (publ)
Stock Price & Overview

$0.480.00 (0.00%)12:40 PM 09/05/23
Expert Market | $USD | Delayed


Div Rate (TTM)
Yield (TTM)
Short Interest
Market Cap
Prev. Close

Quant Ranking

Company Profile

Senzime AB (publ) logo
Senzime AB (publ), a medical device company, develops, manufactures, and markets patient monitoring systems to monitor patients in Europe and the United States. The company offers TetraGraph, a quantitative neuromuscular transmission monitor; TetraSens for measurement of muscle response to a stimulus; TetraSens Pediatric for decision support; TetraConnect, a data management portal that helps to access, view, and export data records from the TetraGraph in PDF or Excel format; TetraGraph Device Connectivity, which transfers data from the TetraGraph Monitor to patient monitoring systems; and ExSpiron 2Xi, a non-invasive respiratory volume monitor, as well as TetraGraph Philips Interface that enables the transmission of neuromuscular monitoring parameters, TOFC, TOFR, PTC, and TOF bars to Philips patient monitors, as well as TetraGraph readings are displayed on the Philips Intellivue Monitor. It also develops CliniSenz Analyzer for postoperative and continuous patient monitoring in hospital environments; and OnZurf Probe, a sterile single use product based on micro-dialysis technology that enables continuous sampling from gastro-intestinal organs, such as esophagus, stomach, and liver. Senzime AB (publ) has a strategic license and connectivity agreement with Masimo to develop and market the TetraGraph Smart Cable Module that connects directly to Root monitoring system, as well as to their digital hubs to interface with the hospital clinical information system/electronic health records. The company was incorporated in 1999 and is based in Uppsala, Sweden.
  • Ulls vAeg 41
  • Uppsala, 756 51
  • Sweden
Phone Number
46 18 51 56 40
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.